Aireen®

Aireen® DR is medical device SW based on artificial intelligence. It provides non-invasive, pain-less screening of chronic diseases by analysing digital images of the retina. The retina is the only place in the human body where blood vessels can be seen by the naked eye. Artificial intelligence is cutting-edge breakthrough technology which allows for the precise identification of changes to the retina. It does so using the unique neural network models which Aireen® DR has created on the basis of:

  • Over 1 million images which have been annotated in collaboration with leading retina specialists from prestigious eye clinics.

Since May 2023 Aireen® diabetic retinopathy screening has been certified as class IIb EU-MDR medical device.

Naše ocenění

Czech DIGI@MED Award 2020

Winner in the category Idea, Idea, Prototype 2020 of the prestigious prize under the patronage of Roche.

Vodafone Idea of 2021

Grand prize winner. First place in the competition of more than 150 projects.

Profinit Technology Project of 2021

Profinit Special Award Winner.

Koop Inno 2021

Winner of the special prize of the insurance company Kooperativa.

Microsoft Partner Awards

Winner of the Machine Learning & AI category in a broad competition of Microsoft partner solutions.